{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:41:21Z","timestamp":1785156081284,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[1996,9,1]],"date-time":"1996-09-01T00:00:00Z","timestamp":841536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1996,9,1]],"date-time":"1996-09-01T00:00:00Z","timestamp":841536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gen Intern Med"],"published-print":{"date-parts":[[1996,9]]},"DOI":"10.1007\/bf02599596","type":"journal-article","created":{"date-parts":[[2007,4,3]],"date-time":"2007-04-03T10:36:04Z","timestamp":1175596564000},"page":"505-512","source":"Crossref","is-referenced-by-count":48,"title":["Interpreting results of prostate-specific antigen testing for early detection of prostate cancer"],"prefix":"10.1007","volume":"11","author":[{"given":"James B.","family":"Meigs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Oesterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02599596_CR1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.273.7.548","volume":"273","author":"AL Potosky","year":"1995","unstructured":"Potosky AL, Miller BA, Albertson PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 1995;273:548\u201352.","journal-title":"JAMA"},{"key":"BF02599596_CR2","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/jama.274.18.1445","volume":"274","author":"SJ Jacobsen","year":"1995","unstructured":"Jacobsen SJ, Katusic SK, Bergstralh EJ, et al. Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. JAMA. 1995;274:1445\u20139.","journal-title":"JAMA"},{"issue":"suppl","key":"BF02599596_CR3","first-page":"127","volume":"11","author":"JB Meigs","year":"1996","unstructured":"Meigs JB, Barry MJ, Rimm EB, Giovannucci E, Stampfer MJ, Kawachi I. Are the wrong men receiving PSA testing for early detection of prostate cancer? The Health Professionals Follow-up Study. J Gen Intern Med. 1996;11(suppl):127. Abstract.","journal-title":"J Gen Intern Med"},{"key":"BF02599596_CR4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000475302","volume":"25","author":"PD Sershon","year":"1994","unstructured":"Sershon PD, Barry MJ, Oesterling JE. Serum prostate-specific antigen discriminates weakly between men with benign prostatic hyperplasia and patients with organ-confined prostate cancer. Eur Urol. 1994;25:281\u20137.","journal-title":"Eur Urol"},{"key":"BF02599596_CR5","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1002\/1097-0142(19910615)67:12<2949::AID-CNCR2820671202>3.0.CO;2-X","volume":"67","author":"C Mettlin","year":"1991","unstructured":"Mettlin C, Lee F, Drago J, Murphy GP. The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men. Cancer. 1991;67:2949\u201358.","journal-title":"Cancer"},{"key":"BF02599596_CR6","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0022-5347(17)35233-3","volume":"151","author":"WJ Catalona","year":"1994","unstructured":"Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol. 1994;151:1283\u201390.","journal-title":"J Urol"},{"key":"BF02599596_CR7","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1056\/NEJM198710083171501","volume":"317","author":"TA Stamey","year":"1987","unstructured":"Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 1987;317:909\u201316.","journal-title":"N Engl J Med"},{"key":"BF02599596_CR8","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0022-5347(17)38491-4","volume":"145","author":"JE Oesterling","year":"1991","unstructured":"Oesterling JE. Prostate specific antigen. A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol. 1991;145:907\u201323.","journal-title":"J Urol"},{"key":"BF02599596_CR9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1464-410X.1995.tb07346.x","volume":"75","author":"D Gillatt","year":"1995","unstructured":"Gillatt D, Reynard JM. What is the normal \u2018range\u2019 for prostate-specific antigen? Use of a receiver operating characteristic curve to evaluate a serum marker. Br J Urol. 1995;75:341\u20136.","journal-title":"Br J Urol"},{"key":"BF02599596_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1001\/jama.273.4.289","volume":"273","author":"PH Gann","year":"1995","unstructured":"Gann PH, Hennekens CH, Stampfer MJ. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA. 1995;273:289\u201394.","journal-title":"JAMA"},{"key":"BF02599596_CR11","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1001\/jama.270.7.860","volume":"270","author":"JE Oesterling","year":"1993","unstructured":"Oesterling JE, Jacobsen SJ, Chute CG, et al. Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges. JAMA. 1993;270:860\u20134.","journal-title":"JAMA"},{"key":"BF02599596_CR12","first-page":"125","volume-title":"Textbook of Benign Prostatic Hyperplasia","author":"JB Meigs","year":"1996","unstructured":"Meigs JB, Barry MJ. The natural history of benign prostatic hyperplasia. In: Kirby RS, McConnell JD, Fitzpatrick JM, Roehrborn CG, Boyle P, eds. Textbook of Benign Prostatic Hyperplasia. Oxford, UK: Isis Medical Media, Ltd; 1996;125\u201335."},{"key":"BF02599596_CR13","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJM199210223271701","volume":"327","author":"GJ Gormley","year":"1992","unstructured":"Gormley GJ, Stoner E, Bruskewitz RC, et al. The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med. 1992;327:1185\u201391.","journal-title":"N Engl J Med"},{"key":"BF02599596_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/pros.2990220105","volume":"22","author":"HA Guess","year":"1993","unstructured":"Guess HA, Heyse JF, Gormley. GJ. The effect of finasteride on prostate-specific antigen in men with benign prostatic hyperplasia. Prostate. 1993;22:31\u20137.","journal-title":"Prostate"},{"key":"BF02599596_CR15","volume-title":"Clinical Epidemiology: A Basic Science for Clinical Medicine","author":"DL Sackett","year":"1991","unstructured":"Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine. Boston, Mass: Little, Brown and Co; 1991."},{"key":"BF02599596_CR16","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/0895-4356(91)90128-V","volume":"44","author":"DL Simel","year":"1991","unstructured":"Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol. 1991;44:763\u201370.","journal-title":"J Clin Epidemiol"},{"key":"BF02599596_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0090-4295(99)80151-4","volume":"46","author":"MJ Barry","year":"1995","unstructured":"Barry MJ, Fleming C, Coley CM, Wasson JH, Fahs MC, Oesterling JE. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? A four part policy analysis, part I: framing the debate. Urology. 1995;46:2\u201313.","journal-title":"Urology"},{"key":"BF02599596_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0895-4356(93)90012-P","volume":"46","author":"DL Simel","year":"1993","unstructured":"Simel DL, Samsa GP, Matchar DB. Likelihood ratios for continuous test results\u2014making the clinicians\u2019 job easier or harder? J Clin Epidemiol. 1993;46:85\u201393.","journal-title":"J Clin Epidemiol"},{"key":"BF02599596_CR19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-5347(17)35405-8","volume":"150","author":"CG Chute","year":"1993","unstructured":"Chute CG, Panser LA, Girman CJ, et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol. 1993;150:85\u20139.","journal-title":"J Urol"},{"key":"BF02599596_CR20","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","volume":"148","author":"M Barry","year":"1992","unstructured":"Barry M, Fowler F, O\u2019Leary M, et al. The American Urological Association Symptom Index for benign prostatic hyperplasia. J Urol. 1992;148:1549\u201357.","journal-title":"J Urol"},{"key":"BF02599596_CR21","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","volume":"324","author":"WJ Catalona","year":"1991","unstructured":"Catalona WJ, Smith DS, Ratliff TL, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991;324:1156\u201361.","journal-title":"N Engl J Med"},{"key":"BF02599596_CR22","volume-title":"Guide to Clinical Preventive Services","author":"U.S. Preventive Services Task Force","year":"1996","unstructured":"U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Baltimore, Md: William and Wilkins; 1996.","edition":"2nd ed."},{"key":"BF02599596_CR23","volume-title":"American Urological Association Executive Committee Report, 1992","author":"American Urological Association","year":"1992","unstructured":"American Urological Association. American Urological Association Executive Committee Report, 1992. Baltimore, Md: American Urological Association; 1992."},{"key":"BF02599596_CR24","first-page":"42","volume":"43","author":"C Mettlin","year":"1993","unstructured":"Mettlin C, Jones G, Averette H, Gusberg SB, Murphy GP. Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. CA. 1993;43:42\u20137.","journal-title":"CA"},{"key":"BF02599596_CR25","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1001\/jama.267.16.2215","volume":"267","author":"HB Carter","year":"1992","unstructured":"Carter HB, Pearson JD, Metter EJ, et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA. 1992;267:2215\u201320.","journal-title":"JAMA"},{"key":"BF02599596_CR26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/0090-4295(93)90364-G","volume":"42","author":"M Riehmann","year":"1993","unstructured":"Riehmann M, Rhodes PR, Cook TD, Grose GS, Bruskewitz RC. Analysis of variation in prostate-specific antigen values. Urology. 1993;42:390\u20137.","journal-title":"Urology"},{"key":"BF02599596_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/00005392-199501000-00036","volume":"153","author":"MJ; Barry","year":"1995","unstructured":"Barry MJ; Girman CJ, O\u2019Leary MP, et al. Using repeated measures of symptom score, uroflowmetry and prostate specific antigen in the clinical management of, prostate disease. J Urol. 1995;153:99\u2013103.","journal-title":"J Urol"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02599596.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02599596\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02599596","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02599596.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T06:31:55Z","timestamp":1652596315000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02599596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1996,9]]}},"alternative-id":["BF02599596"],"URL":"https:\/\/doi.org\/10.1007\/bf02599596","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,9]]}}}